DKG certification ensures pancreatic cancer patients receive treatment at high-volume centers with documented superior outcomes. Research shows median survival at certified hospitals is 8 months. This is nearly double the 4.4 months found at non-certified facilities. These centers follow strict, evidence-based S3-guidelines for all care stages.
- Survival rates: Certified centers report up to 23% lower risk of death for patients.
- Surgical volume: High-volume teams perform 20–50 Whipple procedures yearly, reducing post-operative risks.
- Tumor board: Experts in oncology, surgery, and radiology collaborate on every personalized care plan.
- Integrated care: Patients access psycho-oncology, nutritional counseling, and social services alongside medical therapy.
Bookimed Expert Insight: Data from leading German clinics like Medical Center in Solingen and Asklepios Hospital Barmbek highlights that DKG certification often correlates with massive patient volumes, reaching 60,000 to 110,000 patients annually. While many assume university hospitals are always the top choice, certification status is the more reliable indicator of specific expertise in complex pancreatic surgeries. For instance, Prof. Dr. Thomas W. Kraus at Nordwest Clinic has performed 3,000+ gastrointestinal interventions, illustrating the deep specialization found in these accredited hubs.
Patient Consensus: Patients emphasize that traveling to a certified center is a game-changer because staff provide detailed information and high-quality coordination. Those treated at Asklepios Hospital Barmbek particularly value the presence of highly qualified doctors and the absence of language barriers during complex treatments.